Education:

2016 – Present:   Ph.D student in Department of Cellular Therapy, Oslo University Hospital, Norway

2014 – 2016       M.Sc. in Molecular Bilogy and Genetics, Bilkent University, Ankara, Turkey

2010 – 2014       B.Sc. in Molecular Bilogy and Genetics, Bilkent University, Ankara, Turkey

Research interests/projects:

• Immunotherapy
• Therapeutic TCRs
• Checkpoint Inhibitors
• Chimeric Antigen Receptors (CAR)
• Cloning, expression and functional tests

Work experience

2016 (Oct) – Present      Research Member, Ph.D. candidate at Department of Cellular Therapy, OUS Radiumhospitalet, Oslo, NORWAY

2014-2016                      Research Member, M.Sc. candidate at THORLAB. Memory-like T cells transduced with tumor-specific epitope elicited pronounced cytotoxic potential. Ihsan Dogramaci Bilkent University, Molecular Biology and Genetics Department, Ankara, TURKEY.

2013-2014 Fall               Senior student at Prof. Ihsan Gursel Group. Cloning of TLR-9 and its interaction with different ligands. Ihsan Dogramaci Bilkent University, Molecular Biology and Genetics Department, Ankara, TURKEY.

June-Sept. 2013             Intern at Prof. Leo Joosten and Prof. Mihai Netea Group. ERASMUS Summer Internship Scholarship. NOD-like receptor protein-12 (NLRP12) gene polymorphism G39V in inflammatory bowel disease and Olecranon Bursitis patients` immune responses to Pseudallescheria boydii infection. Nijmegen Institute for Infection, Inflammation & Immunity, Nijmegen, NETHERLANDS.

2012-2013                      Intern at Prof. Ihsan Gursel Group. Ihsan Dogramaci Bilkent University, Molecular Biology and Genetics Department, Ankara, TURKEY.

2010-2012                      Intern at Assist. Prof. Ebru Erbay Group. TUBITAK 2209 project. Discovery of potential substrates of PKR via chemical genetic methods.  Ihsan Dogramaci Bilkent University, Molecular Biology and Genetics Department, Ankara, TURKEY.